Nutex Health is trading 9.1% down at $179.05 in pre-market on October 15, 2026, amid equity pressure after hotter-than-expected U.S. inflation data renewed interest-rate concerns.
- No clear company-specific announcement explaining the drop surfaced; the prior after-hours report described a 6.05% decline amid broader market weakness.
- Reuters reported healthcare stocks ended higher on October 14, so sector weakness does not appear to explain the decline.